Asep Medical Holdings Inc
Other OTCTotal Valuation
Asep Medical Holdings Inc carries a market capitalization of 121,249.00, placing it among publicly traded companies globally.
| Market Cap | 121,249.00 |
| Enterprise Value | N/A |
Share Statistics
Asep Medical Holdings Inc currently has 7.68M shares outstanding.
| Shares Outstanding | 7.68M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 15.97, and the price-to-book ratio stands at 0.55.
| PE Ratio | N/A |
| PS Ratio | 15.97 |
| PB Ratio | 0.55 |
| P/TBV Ratio | -1.86 |
| P/FCF Ratio | -3.51 |
| P/OCF Ratio | -3.50 |
Financial Position
Asep Medical Holdings Inc maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.04 |
| Quick Ratio | 0.03 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 160.54 |
Financial Efficiency
| Return on Equity (ROE) | -55.44 |
| Return on Assets (ROA) | -19.26 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Asep Medical Holdings Inc's stock has declined approximately -97.18346% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.13.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.18346% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.13 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Asep Medical Holdings Inc generated 243,923.00 in revenue and converted that into -4.64M in net income, yielding earnings per share of -0.73. EBITDA reached -3.61M, while operating income came in at -4.92M.
| Revenue | 243,923.00 |
| Gross Profit | 88,731.00 |
| Operating Income | -4.92M |
| Pretax Income | -5.51M |
| Net Income | -4.64M |
| EBITDA | -3.61M |
| EBIT | -4.92M |
| Earnings Per Share (EPS) | -0.73 |
Balance Sheet
Total book value stands at 7.04M, with working capital of -2.26M providing operational flexibility.
| Cash & Cash Equivalents | 12,284.00 |
| Total Debt | N/A |
| Net Debt | 9,882.00 |
| Equity (Book Value) | 7.04M |
| Book Value Per Share | 0.93 |
| Working Capital | -2.26M |
Cash Flow
Asep Medical Holdings Inc produced -1.11M in operating cash flow over the past twelve months. After subtracting -1,250.00 in capital expenditures, free cash flow totaled -1.11M - equivalent to -0.15 per share.
| Operating Cash Flow | -1.11M |
| Capital Expenditures | -1,250.00 |
| Free Cash Flow | -1.11M |
| FCF Per Share | -0.15 |
Margins
Asep Medical Holdings Inc operates with a gross margin of 36.38, reflecting its pricing power and cost economics. The operating margin of -2,017.80 and net profit margin of -1,900.29 provide insight into operational efficiency.
| Gross Margin | 36.38 |
| Operating Margin | -2,017.80 |
| Pretax Margin | -2,258.61 |
| Profit Margin | -1,900.29 |
| EBITDA Margin | -1,482.00 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -22.14 |
| FCF Yield | -28.51 |
Stock Splits
Asep Medical Holdings Inc's most recent stock split took place on April 17, 2025 with a 10:1 split ratio.
| Last Split Date | 4/17/2025 |
| Split Ratio | 10:1 |
Scores
Asep Medical Holdings Inc posts an Altman Z-Score of -18.16, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -18.16 |